Matches in Nanopublications for { ?s ?p "[These data implicate RAN in BCR-ABL1 kinase-independent imatinib resistance and show that shRNA library screens are useful to identify alternative pathways critical to drug resistance in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[These data implicate RAN in BCR-ABL1 kinase-independent imatinib resistance and show that shRNA library screens are useful to identify alternative pathways critical to drug resistance in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1254097.RAAncjge38_keQ9USyV48UVwJFvmRoPvKpJSXi09iwEpM130_assertion description "[These data implicate RAN in BCR-ABL1 kinase-independent imatinib resistance and show that shRNA library screens are useful to identify alternative pathways critical to drug resistance in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1254097.RAAncjge38_keQ9USyV48UVwJFvmRoPvKpJSXi09iwEpM130_provenance.
- assertion description "[These data implicate RAN in BCR-ABL1 kinase-independent imatinib resistance and show that shRNA library screens are useful to identify alternative pathways critical to drug resistance in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1254099.RAVUSqt5yMptAtETS0uzkQcFwan5CEHtnW-OXtK7O_egg130_assertion description "[These data implicate RAN in BCR-ABL1 kinase-independent imatinib resistance and show that shRNA library screens are useful to identify alternative pathways critical to drug resistance in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1254099.RAVUSqt5yMptAtETS0uzkQcFwan5CEHtnW-OXtK7O_egg130_provenance.
- assertion description "[These data implicate RAN in BCR-ABL1 kinase-independent imatinib resistance and show that shRNA library screens are useful to identify alternative pathways critical to drug resistance in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1254098.RAIvFTtt6eY4PUT8W8EOiavKqmgyDiOyiCxWPzC84v_TU130_assertion description "[These data implicate RAN in BCR-ABL1 kinase-independent imatinib resistance and show that shRNA library screens are useful to identify alternative pathways critical to drug resistance in CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1254098.RAIvFTtt6eY4PUT8W8EOiavKqmgyDiOyiCxWPzC84v_TU130_provenance.